Japan is set to develop its own genome editing technology, with the Economy, Trade and Industry Ministry providing funding of ¥8.6 billion ($79.6 million) for the next five years to companies, as well as R&D and academic institutes. In fiscal 2016, the ministry will provide ¥1.72 billion ($15.9 million) for pertinent projects that are submitted […]
On March 23, a new measure to increase the percentage of the blend of biodiesel with diesel fuel was signed into law by Brazlian President Dilma Rouseff. The percentage increase is mandatory for Brazil, the world’s second largest market for biodiesel. By 2017, the blend of biodiesel with diesel fuel will increase to 8% from […]
According to a report entitled “International Comparative Performance of India’s Research Base (2009–2014)” released in February 2016, India’s research publication output has increased greatly since 2009, growing from 3.1% to 4.4% of the world’s total science research publication output in 2013, which equals a CAGR of 13.9%. In 2013, India released 106,065 papers, a 68.5% […]
Writing in the New England Journal of Medicine, the National Cancer Institute’s Douglas R. Lowy, MD, and the NIH’s Francis S. Collins, MD, PhD, summarized the agenda for the US government’s latest cancer research initiative (see IBO 2/15/16). Among the reasons that a new effort is needed at this time is technological progress and scientific […]
A report examining 56 countries’ contributions to the global biopharmaceutical sector based on their respective national policies was released this month. It found that the US, Switzerland and Taiwan are the top three countries whose innovations in life sciences are helping grow the biopharma industry, while India, South Africa and Thailand have policies that are […]
Biotage Benefits from Currency Biotage fourth quarter 2015 sales grew 22.4%, 6.4% excluding currency, to SEK 168.5 million ($19.8 million = SEK 8.50 = $1). Gross margin improved 157 basis points to 56.0% of sales. Adjusted for a one-time write-down in the previous year, operating profit advanced 200 basis points to 12.0%. Currency also appreciably […]
Melbourne, Australia 4/5/16—Trajan Scientific and Medical, a provider of products for biological, environmental and food-related measurements, has purchased automation provider LEAP Technologies for an undisclosed amount. LEAP Technologies provides solutions for automation of GC, LC and MS systems. “Trajan has a technology-rich development pipeline of disruptive sampling and sample preparation products speeding towards commercialization, and […]
San Francisco, CA and Tel Aviv, Israel 4/6/16—DNA synthesis firm Twist Bioscience has acquired Genome Compiler, a provider of software for genetic engineers, and molecular and synthetic biologists. Financial details were not provided. “They are the leader in developing software that allows design of gene sequences for synthetic and molecular biology experiments,” stated Twist Bioscience […]
Waltham, MA 4/4/16—Bioprocessing product firm Repligen has acquired Atoll, based in Weingarten, Germany, for $22.5 million, including $9.1 million in cash, from UV-Cap. Atoll provides the MediaScout family of prepacked chromatography columns for process development and clinical manufacturing of biologic drugs. Repligen stated that the acquisition expands its prepacked column LC product line into high-throughput […]
London, UK and Alexandria, MN 4/6/16—Life sciences and measurement firm LGC has acquired a majority stake in Douglas Scientific from Kingdom Enterprises. Douglas Scientific supplies high-throughput PCR and qPCR platforms, and Array Tape consumables. “Customers will benefit from the unique synergies between our two organizations, including: combined workflow solutions for extraction, genotyping and gene expression […]
Pay Invoice
Latest Blogs
-
Paving The Way for Change: 10x Genomics Announces Corporate Strategies for a Fruitful 2025
February 26, 2025 1:05 pm
-
SLAS2025: Lab Automation and More
January 23, 2025 4:00 pm
-
LAUDA: Temperature Control Innovation
December 10, 2024 4:11 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.